Markets:

Overview

News

Currencies

International

Treasuries

Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

4.450 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Atara Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

12 Health Care Stocks Moving In Friday's After-Market Session ↗

May 31, 2024

Via Benzinga

ATRA Stock Earnings: Atara Biotherapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

ATRA stock results show that Atara Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

May 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

April 08, 2024

Via Benzinga

ATRA Stock Earnings: Atara Biotherapeutics Misses EPS, Misses Revenue for Q4 2023 ↗

March 28, 2024

ATRA stock results show that Atara Biotherapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Atara Biotherapeutics: Q4 Earnings Insights ↗

March 28, 2024

Via Benzinga

Where Atara Biotherapeutics Stands With Analysts ↗

November 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

March 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 06, 2024

Via Benzinga

Why 4D Molecular Therapeutics Shares Are Trading Higher By 20%; Here Are 20 Stocks Moving Premarket ↗

February 05, 2024

Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading. 4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150...

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 02, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

January 15, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 25, 2023

Via Benzinga

Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

December 22, 2023

Shares of AAR Corp. (NYSE: AIR) fell during Friday’s session after the company reported mixed second-quarter financial results.

Via Benzinga

Why Rocket Lab Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

December 22, 2023

Shares of Rocket Lab USA, Inc. (NASDAQ: RKLB) shares rose sharply in pre-market trading after the company announced a new $515 million contract with a U.S. government customer.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 07, 2023

Via Benzinga

Dow Falls Over 200 Points; Krispy Kreme Reports Downbeat Results ↗

November 09, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Thursday. The Dow traded down 0.71% to 33,871.77 while the NASDAQ fell 0.87% to 13,531.36. The S&P 500...

Via Benzinga

Topics Stocks

Why AMC Entertainment Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

November 09, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 09, 2023

Via Benzinga

Crude Oil Rises Over 1%; Tapestry Posts Upbeat Earnings ↗

November 09, 2023

U.S. stocks traded slightly higher midway through trading, with the Nasdaq Composite gaining around 50 points on Thursday. The Dow traded up 0.01% to 34,114.64 while the NASDAQ rose 0.35% to 13,697.53....

Via Benzinga

Topics Stocks

US Stocks Mostly Flat; Jobless Claims Decline In Latest Week ↗

November 09, 2023

U.S. stocks traded mostly flat this morning, following the release of jobless claims data. Following the market opening Thursday, the Dow traded down 0.02% to 34,105.13 while the NASDAQ rose 0.01% to...

Via Benzinga

Topics Stocks

Why AppLovin Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket ↗

November 09, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares surged 111.9% to $0.4810 in pre-market trading after reporting first-quarter results.

Via Benzinga

Astra Space (ASTR) Stock Spikes 82% on Take-Private Proposal ↗

November 09, 2023

Astra Space stock is taking off on Thursday as investors react to a take-private offer for ASTR shares from the company's founders.

Via InvestorPlace

Why Is Assertio (ASRT) Stock Down 39% Today? ↗

November 09, 2023

Assertio stock is dropping on Thursday as investors in ASRT react to the company's poor earnings results for the third quarter of 2023.

Via InvestorPlace

Why Is Atara Biotherapeutics (ATRA) Stock Down 50% Today? ↗

November 09, 2023

Atara Biotherapeutics stock is falling on Thursday as investors in ATRA react to the company's latest Phase 2 clinical trial data.

Via InvestorPlace

Why Atara Biotherapeutics Shares Are Plummeting Today ↗

November 09, 2023

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) shares are trading lower after the company said that primary analysis data from its Phase 2 EMBOLD study of ATA188 in non-active progressive multiple...

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Atara Biotherapeutics, Inc. - Common Stock (NQ:ATRA)

Headline News about Atara Biotherapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today